Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04394806

The Early and Late Contribution of Fasting and Postprandial Triglycerides on Newborn Subcutaneous and Intrahepatic Fat in Pregnancy

Status
Recruiting
Phase
Study type
Observational
Enrollment
140 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
0 Years – 39 Years
Healthy volunteers
Accepted

Summary

This study plans to learn more about how triglyceride levels in pregnancy affect newborn fat mass. Obesity in pregnancy, in the absence of gestational diabetes, is now the most common cause of large-for-gestational-age infants and increased newborn fat mass. Previous data supports the idea that maternal triglycerides, not glucose, are the strongest predictor of both total newborn fat mass and liver fat. In this study, mothers will monitor triglyceride and glucose levels at specific points in pregnancy using point-of-care meters at home. Two weeks after birth, infants will have total fat measured by air-displacement plethysmography (PEAPOD) and liver fat measures by Magnetic Resonance Spectroscopy (MRS). The central hypothesis is that in obesity, fasting triglycerides and postprandial triglycerides will predict newborn fat mass in a free-living environment.

Conditions

Timeline

Start date
2022-03-01
Primary completion
2027-07-01
Completion
2027-07-01
First posted
2020-05-19
Last updated
2024-10-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04394806. Inclusion in this directory is not an endorsement.